Christoph Lange was recently appointed as Medical Director of the Research Center Borstel. From here, he substantially contributes to clinical tuberculosis research in Europe, also monitoring the
The latest outbreaks of emerging, dangerous pathogens, such as Ebola, MERS-CoV or Zika, emphasise the importance of the rapid development of effective vaccines. However, being able to predict the
Scientists from the German Center for Infection Research (DZIF) are on a specific quest for the causes of and biomarkers for severe courses of Pfeiffer’s disease. The disease is caused by the Epstein
A team of researchers from the Heinrich Pette Institute and the USA have succeeded in identifying a protein called HLA-F which functions as the ligand of an activating natural killer cell receptor
DZIF scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have succeeded in identifying and targeting problematic pathogens in biofilms more rapidly. The biofilm adhesion
In a treatment centre in Guinea, DZIF researchers from the Heinrich Pette Institute (HPI) and the Bernhard Nocht Institute (BNITM) have, for the first time, identified the human immune response in
Rapid and reliable diagnosis of paediatric tuberculosis is still an ongoing problem. The most important prerequisite for successful treatment of active tuberculosis is its early diagnosis. A team of
Researchers from the German Center for Infection Research (DZIF) in Hannover, Munich and Tübingen have now signed a cooperation agreement for the new Center for Gastrointestinal Microbiome Research
